|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 498/22 | |
| A61K 31/437 | |||
| A61P 31/04 |
| (11) | Patento numeris | 2536734 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11745134.4 |
| Europos patento paraiškos padavimo data | 2011-02-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-12-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-08-31 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/024981 |
| Data | 2011-02-16 |
| (87) | Numeris | WO 2011/103120 |
| Data | 2011-08-25 |
| (30) | Numeris | Data | Šalis |
| 708836 | 2010-02-19 | US |
| (72) |
GUSHURST, Karen, S., US
YANG, Donglai, US
VLAHOVA, Petinka, US
STULTS, Jeffrey, S., US
|
| (73) |
Salix Pharmaceuticals, Ltd.,
400 Somerset Corporate Blvd., Bridgewater, NJ 08807,
US
|
| (54) | FORMS OF RIFAXIMIN AND USES THEREOF |
| FORMS OF RIFAXIMIN AND USES THEREOF |